(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.29%.
Whitehawk Therapeutics's earnings in 2025 is $27,614,000.On average, 2 Wall Street analysts forecast WHWK's earnings for 2025 to be -$87,152,192, with the lowest WHWK earnings forecast at -$111,649,024, and the highest WHWK earnings forecast at -$62,655,360. On average, 2 Wall Street analysts forecast WHWK's earnings for 2026 to be -$82,912,356, with the lowest WHWK earnings forecast at -$120,128,697, and the highest WHWK earnings forecast at -$45,696,014.
In 2027, WHWK is forecast to generate -$101,284,980 in earnings, with the lowest earnings forecast at -$101,284,980 and the highest earnings forecast at -$101,284,980.